Infant Bacterial Therapeutics AB logo

IBT B - Infant Bacterial Therapeutics AB News Story

SEK110.4 -1.2  -1.1%

Last Trade - 14/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £105.5m
Enterprise Value £69.3m
Revenue £n/a
Position in Universe 879th / 1832

BRIEF-Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 27.9 Mln

Fri 14th August, 2020 7:12am
Aug 14 (Reuters) - Infant Bacterial Therapeutics AB
 IBTb.ST :
    * Q2 OPERATING LOSS SEK 27.9 MILLION VERSUS LOSS SEK 7.9
MILLION
YEAR AGO
    * Q2 RESULT AFTER TAX LOSS SEK 27.9 VERSUS LOSS SEK 7.6
MILLION
YEAR AGO

Source text for Eikon:  ID:nGNE7bjtmK 
Further company coverage:  IBTb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.